11,338 results found

The US Department of Justice (DOJ) and whistleblowers were party to a record number of False Claims Act settlements and judgments in fiscal year 2023.

The Trump Administration's recent announcement regarding CMS exclusion authority represents a potentially transformative shift in federal healthcare enforcement. This development could significantly expand the government's capacity to exclude providers from Medicare and Medicaid participation, raising critical questions about how responsibilities will be divided between CMS and OIG. Healthcare organizations with substantial federal program participation face new compliance considerations as enforcement mech

As 2013 came to a close, the United States District Court dismissed a complaint filed under the federal False Claims Act and the Anti-Kickback Law – and numerous state and local laws – alleging a kickback scheme associated with hemophilia medication.

Policy Shifts at the Department of Justice – 2018 in Review provides an easily navigated yet detailed summary of significant developments at the Department of Justice (DOJ) focusing on fraud and abuse

In December 2018, the Department of Justice (DOJ) formalized its position on limiting the use of guidance documents issued by federal agencies to govern its prosecution decisions.

The Advisory Opinion was requested by a physician who was excluded for 20 years from Medicare participation as part of a a criminal plea and settlement of a civil False Claims Act settlement.

In United States ex rel. Benjamin Poehling v. UnitedHealth Group, Inc. et al., Case No. CV 16-08697 (C.D. Cal. Feb. 18, 2018), the court dismissed only half of the claims in a qui tam case...

On the heels of the end of the comment period for input on reducing the regulatory burdens of the Physician Self-referral Law (also known as the "Stark Law") on August 24, the Department of Health and Human Services, ...

On Friday, November 20, 2020, the Department of Health and Human Services (HHS) released four significant Final Rules, including the Office of Inspector General (OIG) rule:

In June 30, the U.S. Department of Justice (DOJ) released an interim final rule that implements provisions of the Bipartisan Budget Act of 2015 (Act) which updated civil monetary penalties assessed or enforced by the DOJ that had not been changed for years.

Health Diagnostic Laboratory in Virginia and several other labs are under investigation by the Office of Inspector General and Justice Department.

Late last month the U.S. Attorney's Office for the District of Connecticut issued a press release regarding the latest False Claims Act (FCA) settlement involving the healthcare industry

A July 19 article in Bloomberg BNA's Health Care Fraud Report and other publications, "Nurses Hit Hardest by Medicare and Medicaid Exclusions," discussed the exclusion of nurses and physicians from participation in the Medicare and Medicaid programs.

The Office of Inspector General (OIG) of the Department of Health and Human Services posted an Advisory Opinion today addressing a hospital system's proposal to lease administrative employees...

The HHS OIG recently issued a brief fraud alert reminding physicians that inappropriate compensation arrangements may lead to enforcement actions under the federal anti-kickback statute and Civil Monetary Penalties Law.

On June 9, the Office of Inspector General of the U.S. Department of Health and Human Services issued a fraud alert regarding the risk of liability to physicians arising out of legitimate compensation arrangements...

The Office of Inspector General (OIG) of the Department of Health and Human Services (HHS) is inviting public recommendations for new or modified safe harbor provisions under the federal anti-kickback statute.

This week, the U.S. Department of Justice indicted 14 owners and senior officials of a Massachusetts pharmacy that manufactured and distributed contaminated drugs that killed 64 people in a 2012 fungal meningitis outbreak.